FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
1.020
-0.030 (-2.86%)
May 22, 2026, 11:19 AM EDT - Market open
FibroBiologics Market Cap
FibroBiologics has a market cap or net worth of $5.51 million as of May 22, 2026. Its market cap has decreased by -84.10% in one year.
Market Cap
5.51M
Enterprise Value
6.67M
1-Year Change
-84.10%
Ranking
Category
Stock Price
$1.02
Market Cap Chart
Since January 31, 2024, FibroBiologics's market cap has decreased from $945.52M to $5.51M, a decrease of -99.42%. That is a compound annual growth rate of -89.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 21, 2026 | 5.67M | -62.11% |
| Dec 31, 2025 | 14.96M | -78.68% |
| Dec 31, 2024 | 70.17M | -92.58% |
| Jan 31, 2024 | 945.52M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Virax Biolabs Group | 6.20M |
| XTL Biopharmaceuticals | 6.19M |
| GeoVax Labs | 6.07M |
| TransCode Therapeutics | 6.02M |
| CollPlant Biotechnologies | 5.95M |
| Alaunos Therapeutics | 5.90M |
| CDT Equity | 5.88M |
| Moolec Science | 5.44M |